We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo ADLM 2026 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Image: Visual Abstract (Seemesh Bhaskar et al., Point of care molecular cancer diagnostics, Lab on a Chip, 2026. DOI: 10.1039/d5lc01014d)

Point-of-Care Molecular Technology Promises Transformative Shift in Oncology

New findings chart how POC molecular diagnostics speed cancer detection and treatment decisions with near-patient results. More...
22 Jul 2026
Image: FirstGene delivers fetal chromosome, fetal single-gene, patient carrier, and fetal RhD screening in one integrated report (Photo courtesy of Myriad Genetics)

New Test Delivers Four Prenatal Genetic Screens from One Blood Sample

Myriad Genetics has launched FirstGene, a single-sample prenatal test that performs four genetic screens simultaneously. More...
22 Jul 2026
Image Credit: Adobe Stock

Genetic Variations Reveal Mechanisms Behind Sudden Cardiac Death Risk

New findings profile gene variants and map protein defects, improving genetic test interpretation for inherited heart muscle disease. More...
22 Jul 2026
Image: The acquisition brings together Personalis’ MRD technology with Tempus’ commercial scale, multimodal data, and AI platform to advance cancer monitoring, deepen insights, and accelerate growth

Tempus to Acquire Personalis in $1.5 Billion Precision Oncology Deal

Tempus AI has entered into a definitive agreement to acquire Personalis, expanding its capabilities in MRD testing and cancer monitoring. More...
22 Jul 2026
Image: Despite treatment advances, most multiple myeloma patients relapse and identifying high-risk cases at diagnosis remains challenging (Image Credit: Adobe Stock)

New Marker Helps Detect Aggressive Multiple Myeloma Earlier

A new study links elevated cell-adhesion protein levels to shorter survival in newly diagnosed multiple myeloma. More...
22 Jul 2026
Multiplex immunofluorescent (left) and H&E-stained (right) breast tumor samples illustrating high versus low Base Topology Scores. Higher topology scores reflect more organized tissue architecture, while lower scores indicate greater structural disorganization. By quantitatively measuring these structural differences, the researchers developed biomarkers that predicted patient outcomes more accurately than many traditional approaches. (Photo courtesy of Columbia University Irving Medical Center)

Digital Pathology Tool Predicts Breast Cancer Outcomes and Therapy Response

A topology-based approach quantifies tumor architecture to improve breast cancer prognosis and predict therapy response. More...
22 Jul 2026
Image: A new study shows that an ultrasensitive blood test can detect immune signaling patterns associated with Sjögren’s disease more than a decade before diagnosis (Image Credit: 123RF)

Ultrasensitive Blood Test Detects Sjögren’s Signature Years Before Diagnosis

A blood test detects early immune signatures up to a decade before Sjögren’s disease diagnosis. More...
21 Jul 2026
Visit expo >
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
Automated Clinical Chemistry Analyzer
Envoy 500+
HPV Molecular Test
BD Onclarity HPV Assay

In Other News

Copyright © 2000 - 2026 Globetech Media.
All rights reserved.
PURITAN MEDICAL